The company's main business is manufacturing and selling in vitro diagnostic medical devices and diagnostic reagents. In May 19, the company relocated to the KOSDAQ market from the KONEX market.
The company's multi-immune blot system is installed in about 100 domestic medical institutions such as examination centers and general hospitals. Based on this platform technology, various products such as allergy, autoimmunity, and dementia tests are being developed and commercialized.
Sales consist of 72.13% of products, 26.74% of services, and 1.13% of products.
2020/08/11 - [KOSDAQ] - Generation of rapid in vitro diagnostic medical devices
2020/08/04 - [KOSPI] - Korea's leading company for soy sauce and seasoned food, Sam Pyo Food
2020/08/01 - [KOSPI] - Hyosung Heavy Industries is in control of Gamsam-dong in Harrington Place
댓글 영역